Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Future Of TG’s Ukoniq In Question As Drug Attracts Closer FDA Scrutiny
Feb 03 2022
•
By
Alaric DeArment
TG's Ukoniq has come under increased FDA scrutiny over its safety-efficacy profile • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Anticancer
More from Therapy Areas